Otylosc a rak jelita grubego

• Autorzy: Jarosz M , Sajor I.

Warianty tytułu

EN

Obesity and colorectal cancer

• Języki publikacji: PL

Słowa kluczowe

PL

choroby czlowieka; rak jelita grubego; otylosc; czynniki genetyczne; masa ciala; ryzyko zachorowan; otylosc brzuszna; czynnik wzrostu insulinopodobny; opornosc na insuline

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2007
• Tom: 34
• Numer: 6
• Opis fizyczny: s.1614-1618,rys.,tab.,bibliogr.

Twórcy

autor

Jarosz M

• Instytut Zywnosci i Zywienia, Warszawa

autor

Sajor I.

Bibliografia

• 1. World Cancer Research Fund and American Institute for Cancer Research: Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective, Washington DC AICR, 2007.
• 2. Giovannua E., Michaud D.: The role of obesity and related metabolic disturbances in cancers of the colon, prostate and pancreas. Gastroenterology 2007, 132, 2208- 2225.
• 3. Johnson I. T., Luna E. K.: Review article: nutrition, obesity and colorectal cancer. Alim. Pharmacol. Ther., 2007, 26, 161- 181.
• 4. Rakowska-Mrozikiewicz B., Krasnodębski P., Niecisz A., et al.: Czy obecność cukrzycy wpływa na występowanie polipów jelita grubego? Diabetol. Pol., 2007, 13, 1, 53- 58.
• 5. Pischon T., Lahmann P. H., Boeing H., et al.: Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J. Nat. Cancer Inst., 2006, 98, 920- 931.
• 6. Russo A., Franceschi S., La Vecchia C., et al.: Body size and colorectal cancer risk. Int. J. Cancer 1998, 78, 161- 165.
• 7. Giovannucci E., Colditz G. A., Stampfer M. J., Wiolett W. C.: Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 1996, 7, 253- 263.
• 8. Giovannucci E., Ascherio A., Rimm E. B., et al.: Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann. Intern. Med., 1995, 122, 327- 334.
• 9. Adami H. O., Trichopoulos D.: Obesity and Mortality from Cancer. N. Engl. J. Med., 2003, 24, 348, 17.
• 10. Martinez M. E., Giovannucci E., Spiegelman D., et al.: Physical activity, body size, and colorectal cancer in women. Am. J. Epidemiol., 1996, 143, S73.
• 11. Sass D. A., Schoen R. E., Weissfeld J. L., et al.: Relationship of visceral adipose tissue to recurrence of adenomatous polyps. Am. J. Gastroenterol., 2004, 99, 687- 693.
• 12. Otake S., Takeda H., Suzuki Y., et al.: Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin. Cancer Res., 2005, 11, 3642- 3646.
• 13. Giovannucci E.: Nutrition, insulin, insulin-like growth factors and cancer. Horm. Metab. Res., 2003, 35, 694- 704.
• 14. Schoen R. E., Tangen C. M., Kuller L. H., et al.: Increased blood glucose and insulin body size, and incident colorectal cancer. J. Nat. Cancer Inst., 1999, 91, 1147- 1154.
• 15. Wang Y. Y., Lin S. Y., Lai W. A., et al.: Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population. J. Gastroenterol. Hepatol., 2005, 20, 1410- 1415.
• 16. Ahmed R. L., Schmitz K. H., Anderson K. E., et al.: The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006, 107, 28- 36.
• 17. Bowers K., Albanes D., Limburg P., et al.: A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am. J. Epidemiol., 2006, 164, 652- 654.
• 18. Kaczka A., Kumar A., Pietruczuk M., Małecka-Panas E.: Stężenie insuliny C-peptydu (insulinopodobnego czynnika wzrostu) w surowicy chorych z polipem i rakiem jelita grubego. Pol. Merk. Lek., 2007, 22, 131, 373- 375.
• 19. Malinowski M., Krasnodębski P., Mrozikiewicz-Rakowska B., i in.: Ocena narażenia na występowanie stanów nowotworowych jelita grubego u pacjentów z cukrzycą - obserwacja wstępna. Diabetol. Pol., 2007, 13, 1.
• 20. Seow A., Yuan J. M., Koh W. P., et al.: Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J. Nat. Cancer Inst., 2006, 98, 135- 138.
• 21. Elwing J. E., Gao F., Davidson N. O., Early D. S.: Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am. J. Gastroenterol., 2006, 101, 1866- 1871.
• 22. Almendingen K., Hofstad B., Vatn M. H.: Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? Am. J. Gastroenterol., 2001, 96, 2238- 2246.
• 23. Shinchi K., Kono S., Honjo S., et al.: Obesity and adenomatous polyps of the sigmoid colon. Jpn. J. Cancer Res., 1994, 85, 479- 484.
• 24. Larsson S. C., Orsini N., Wolk A.: Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J. Nat. Cancer Inst., 2005, 97, 1679- 1687.
• 25. Bostick R. M., Potter J. D., Kushl L. H., et al.: Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Con­trol 1994, 5, 38- 52.
• 26. Giovannucci E.: Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J. Nutr., 2001, 131, 3109 S- 312 S.
• 27. Colangelo L. A., Gapstur S. M., Gann P. H., et al.: Colorectal cancer mortality and factors related to the insulin resistance syndrome, Cancer Epidemiol. Biomarkers Prev., 2002, 11, 385- 391.
• 28. Saydah S. H., Platz E. A., Rifai N., et al.: Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 2003, 12, 412- 418.
• 29. Giovannucci E.: Insulin and colon cancer. Cancer Causes Control 1995, 6, 164- 179.
• 30. Tran T. T., Medicine A., Bruce R.: Insulin promotion of colon tumors in rats. Cancer Epidemiol. Biomarkers Prev., 1996, 5, 1013- 1015.
• 31. Nilsen T. I., Vatten L. J.: Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br. J. Cancer 2001, 84, 417- 422.
• 32. Trevisan M., Liu J., Muti P., et al.: Markers of insulin resistance and colorectal cancel mortality. Risk Factors and Life Expectancy Research Group. Cancer Epidemiol. Biomarkers Prev., 2001, 10, 937- 94.
• 33. Tran T. T., Naigamwalla D., Oprescu A. I., et al.: Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology 2006, 147, 1830- 1837.
• 34. Keku T. O., Lund P. K., Galanko J., et al.: Insulin ressistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 2076- 2081.
• 35. Wei E. K., Ma J., Poliak M. N., et al.: C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol. Biomarkers Prev., 2006, 15, 750- 755.
• 36. Jones J., Clemmons D.: Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 1995, 16, 3- 34.
• 37. Wei E. K., Ma J., Poliak M. N., et al.: A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 850- 855.
• 38. Thissen J. P., Ketelslegers J. M., Underwood L. E.: Nutritional regulation of the insulin-like growth factors. Endocr. Rev., 1994, 15, 80- 101.
• 39. Frystyk J., Skjaerbaek C., Vestbo E., et al.: Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab. Rev., 1999, 15, 314- 322.
• 40. Ma J., Poliak M. N., Giovannucci E., et al.: Prospective study of colorectal cancer risk in men and plasma levels of insuline-like growth factor (IGF)-l and IGF-binding protein-3. J. Nat. Cancer Inst., 1999, 91, 620- 625.